Lilotomab
More
Less
Lilotomab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Lilotomab Usage And Synthesis
Uses
Lilotomab (HH1) is a murine anti-CD37 monoclonal antibody. Lilotomab reduces clonogenic survival. Lilotomab shows anti-tumor activity[1].
in vivo
Lilotomab (0.5 mg/kg; i.v.; once) inhibits tumor growth in mice[1].
| Animal Model: | SCID mice (DOHH2 cell xenografts)[1] |
| Dosage: | 0.5?mg/kg |
| Administration: | I.v.; once |
| Result: | Inhibited tumor growth and increased mouse survival. |
References
[1] Malenge MM, et al. 177Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin Lymphoma. J Nucl Med. 2020 Oct;61(10):1468-1475. DOI:10.2967/jnumed.119.237230
LilotomabSupplier
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
Guangzhou Hongyuan Chemical Co.,Ltd
- Tel
- 15817493340
- 981810490@qq.com
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
TargetMol Chemicals Inc.
- Tel
- 4008200310
- marketing@tsbiochem.com